Amalgamated Bank Ligand Pharmaceuticals Inc Transaction History

Amalgamated Bank

  • $13.6 Billion
  • Q3 2025

A detailed history of Amalgamated Bank transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Amalgamated Bank holds 5,635 shares of LGND stock, worth $1.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,635
Previous 5,446 3.47%
Holding current value
$1.18 Million
Previous $619,000 61.23%
% of portfolio
0.01%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025
BUY
$112.56 - $177.14 $21,273 - $33,479
189 Added 3.47%
5,635 $998,000
Q2 2025

Aug 04, 2025
BUY
$96.67 - $118.22 $8,313 - $10,166
86 Added 1.6%
5,446 $619,000
Q1 2025

Apr 25, 2025
SELL
$105.14 - $122.23 $17,453 - $20,290
-166 Reduced 3.0%
5,360 $564,000
Q4 2024

Feb 04, 2025
BUY
$99.95 - $129.9 $17,691 - $22,992
177 Added 3.31%
5,526 $592,000
Q3 2024

Oct 30, 2024
BUY
$82.7 - $110.11 $15,795 - $21,031
191 Added 3.7%
5,349 $535,000
Q2 2024

Aug 12, 2024
SELL
$68.53 - $87.91 $10,142 - $13,010
-148 Reduced 2.79%
5,158 $435,000
Q1 2024

Apr 23, 2024
SELL
$68.64 - $89.2 $67,816 - $88,129
-988 Reduced 15.7%
5,306 $388,000
Q4 2023

Feb 06, 2024
SELL
$49.57 - $72.63 $7,683 - $11,257
-155 Reduced 2.4%
6,294 $450,000
Q3 2023

Nov 08, 2023
SELL
$58.86 - $72.67 $14,185 - $17,513
-241 Reduced 3.6%
6,449 $386,000
Q2 2023

Aug 11, 2023
BUY
$69.53 - $79.33 $834 - $951
12 Added 0.18%
6,690 $482,000
Q1 2023

May 02, 2023
SELL
$65.67 - $77.08 $34,279 - $40,235
-522 Reduced 7.25%
6,678 $491,000
Q3 2022

Nov 09, 2022
SELL
$0.01 - $107.56 $2 - $23,232
-216 Reduced 2.91%
7,200 $620,000
Q2 2022

Aug 15, 2022
BUY
$74.52 - $117.06 $3,427 - $5,384
46 Added 0.62%
7,416 $662,000
Q1 2022

Jun 30, 2022
SELL
$94.99 - $151.56 $36,761 - $58,653
-387 Reduced 4.99%
7,370 $829,000
Q4 2021

Feb 15, 2022
SELL
$127.69 - $165.85 $17,365 - $22,555
-136 Reduced 1.72%
7,757 $1.2 Million
Q3 2021

Oct 29, 2021
SELL
$102.33 - $144.73 $433,674 - $613,365
-4,238 Reduced 34.94%
7,893 $1.1 Million
Q2 2021

Aug 16, 2021
BUY
$113.03 - $155.64 $1.12 Million - $1.55 Million
9,937 Added 452.92%
12,131 $1.59 Million
Q1 2021

May 13, 2021
SELL
$99.52 - $215.83 $20,003 - $43,381
-201 Reduced 8.39%
2,194 $334,000
Q4 2020

Feb 12, 2021
BUY
$80.55 - $106.05 $1,933 - $2,545
24 Added 1.01%
2,395 $238,000
Q3 2020

Oct 30, 2020
SELL
$89.56 - $126.72 $6,985 - $9,884
-78 Reduced 3.18%
2,371 $226,000
Q2 2020

Aug 10, 2020
SELL
$68.28 - $123.65 $27,585 - $49,954
-404 Reduced 14.16%
2,449 $274,000
Q1 2020

May 13, 2020
SELL
$63.37 - $107.88 $5,576 - $9,493
-88 Reduced 2.99%
2,853 $207,000
Q4 2019

Feb 13, 2020
SELL
$96.94 - $113.59 $11,923 - $13,971
-123 Reduced 4.01%
2,941 $307,000
Q3 2019

Nov 13, 2019
SELL
$86.25 - $120.16 $5,088 - $7,089
-59 Reduced 1.89%
3,064 $305,000
Q2 2019

Aug 14, 2019
SELL
$107.38 - $129.34 $27,704 - $33,369
-258 Reduced 7.63%
3,123 $356,000
Q1 2019

May 15, 2019
BUY
$105.93 - $142.47 $11,122 - $14,959
105 Added 3.21%
3,381 $425,000
Q4 2018

Feb 15, 2019
BUY
$128.36 - $272.13 $234,513 - $497,181
1,827 Added 126.09%
3,276 $445,000
Q3 2018

Nov 14, 2018
SELL
$211.18 - $274.49 $415,602 - $540,196
-1,968 Reduced 57.59%
1,449 $398,000
Q2 2018

Jul 18, 2018
BUY
$150.77 - $207.98 $69,052 - $95,254
458 Added 15.48%
3,417 $708,000
Q1 2018

May 22, 2018
SELL
$138.63 - $182.62 $6,792 - $8,948
-49 Reduced 1.63%
2,959 $489,000
Q4 2017

Feb 13, 2018
BUY
$128.36 - $147.04 $23,874 - $27,349
186 Added 6.59%
3,008 $412,000
Q3 2017

Nov 09, 2017
BUY
$120.91 - $137.94 $341,208 - $389,266
2,822
2,822 $384,000

Others Institutions Holding LGND

# of Institutions
312
Shares Held
19.9M
Call Options Held
9K
Put Options Held
0
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $3.52B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email